Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Ajooni Biotech LtdIndustry : Food - Processing - Indian
BSE Code:535040NSE Symbol: AJOONIP/E(TTM):32.75
ISIN Demat:INE820Y01021Div & Yield %:0EPS(TTM):0.2
Book Value(Rs):4.6956508Market Cap ( Cr.):57.39Face Value(Rs):2
    Change Company 
Date Headline
07-Feb-24 Ajooni Biotech standalone net profit rises 300.00% in the December 2023 quarter
07-Feb-24 Ajooni Biotech Ltd - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
07-Feb-24 Ajooni Biotech Ltd - Statement of deviation(s) or variation(s) under Reg. 32
07-Feb-24 Ajooni Biotech Ltd - Updates
07-Feb-24 Ajooni Biotech Ltd - Financial Result Updates
07-Feb-24 Ajooni Biotech Ltd - Outcome of Board Meeting
31-Jan-24 Ajooni Biotech to declare Quarterly Result
10-Nov-23 Ajooni Biotech Ltd - Copy of Newspaper Publication
09-Nov-23 Ajooni Biotech standalone net profit rises 150.00% in the September 2023 quarter
06-Nov-23 Ajooni Biotech to conduct board meeting
<< < 1 2 > >>